Literature DB >> 21266292

Onco-geriatric approach for the management of older patients with cancer.

Matteo Cesari1, Giuseppe Colloca, Francesco Cerullo, Alessandro Ferrini, Antonia Carla Testa, Elvira Foti, Michele Ciaburri, Giovanni Scambia, Roberto Bernabei, Giovanni Gambassi.   

Abstract

INTRODUCTION AND RATIONALE: The number of older cancer patients is increasing with global aging of the population. A close interaction between oncologists and geriatricians becomes necessary to (1) better evaluate the elders' health status, (2) determine their residual clinical/biological reserves, and (3) optimize the provided medical care. In fact, aggressive antineoplastic managements are often denied to older patients, possibly because of the common misconception suggesting older age and/or clinical complexity as absolute contraindications to advanced treatments.
METHODS: The primary aim of the presented project is to assess whether assigning a geriatrician to provide daily medical care to older cancer patients (aged 65 years and older) admitted to an oncology ward increases the number of patients eligible for a chemotherapeutic and/or surgical intervention. The project is articulated in 2 phases: (1) a retrospective phase based on analysis of data collected over the 2 years before the beginning of the study, and (2) a prospective 2-year intervention. Additional information about clinical conditions, biological parameters, adverse drug reactions, body composition, physical function, and 1-year health-related events will also be recorded. OUTCOMES: The combination of expertise from oncologists and geriatricians is likely to result in (1) an improved selection of candidates for interventions aimed at increasing disability-free life expectancy and/or overall survival, and (2) a more rational exclusion of patients at higher risk of toxicity or with poor prognosis. In this article, the development of an onco-geriatric unit aimed at the evaluation, management, and treatment of older women with gynecological cancer is also described.
Copyright © 2011 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21266292     DOI: 10.1016/j.jamda.2010.06.008

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  4 in total

1.  Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study.

Authors:  Mario Ulises Pérez-Zepeda; Eduardo Cárdenas-Cárdenas; Matteo Cesari; Ana Patricia Navarrete-Reyes; Luis Miguel Gutiérrez-Robledo
Journal:  J Cancer Surviv       Date:  2016-02-08       Impact factor: 4.442

Review 2.  Integrating oncogeriatric tools into the management of chronic lymphocytic leukemia: current state of the art and challenges for the future.

Authors:  Francesco Merli; Caterina Mammi; Fiorella Ilariucci
Journal:  Curr Oncol Rep       Date:  2015-07       Impact factor: 5.075

Review 3.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.

Authors:  Hans Wildiers; Pieter Heeren; Martine Puts; Eva Topinkova; Maryska L G Janssen-Heijnen; Martine Extermann; Claire Falandry; Andrew Artz; Etienne Brain; Giuseppe Colloca; Johan Flamaing; Theodora Karnakis; Cindy Kenis; Riccardo A Audisio; Supriya Mohile; Lazzaro Repetto; Barbara Van Leeuwen; Koen Milisen; Arti Hurria
Journal:  J Clin Oncol       Date:  2014-08-20       Impact factor: 44.544

4.  Personalised treatment for older adults with cancer: The role of frailty assessment.

Authors:  Anita O'Donovan; Michelle Leech
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2020-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.